New options like semaglutide are becoming more popular
Regulatory & Clinical Safety Disclosures: Compounded formulations of Semaglutide and Tirzepatide are customized medications prepared by licensed 503A compounding pharmacies to meet individual patient needs, but they are not FDA-approved or evaluated for safety and efficacy by the FDA
There was no difference in protein binding between the groups
Ethics declarations Disclosures Katherine Wasden reports receiving the SAGES Medical Student Research Grant
however, EMS personnel need to be alert for the use of counterfeited drug as well
Samita Garg, MD, associate professor of medicine at Cleveland Clinic Lerner College of Case Western Reserve University, and director of multidisciplinary gastroenterology endocrine GLP clinic in the department of gastroenterology, hepatology and nutrition at the Digestive Disease Institute, Cleveland Clinic Foundation, said the prevalence of overweight and obesity has been increasing among people with type 1 diabetes in recent years